News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Combination therapy holds promise as MS treatment

October 04, 2024

Results could lead to a new, more potent option for patients.
Learn more

Applying for disaster relief

October 01, 2024

Instructions for individuals with MS who need disaster relief
Learn more

MS symptoms at onset linked to long-term disability

September 30, 2024

New study reveals blurry vision and sphincter dysfunction as key predictors of functional outcomes in MS patients.
Learn more

Support disaster relief for people with MS

September 30, 2024

Give or get support for disaster relief for people with MS.
Learn more

New study uncovers therapeutic inertia in the treatment of women with MS

September 27, 2024

The findings highlight gender disparities that could affect long-term health outcomes for women of childbearing age.
Learn more

Study finds ancestry-specific genetic variants linked to MS risk

September 24, 2024

Uncovered novel ancestry-specific genetic variants found to be linked to disease.
Learn more

Early high-efficacy treatment reduces long-term disability in children with MS

September 23, 2024

The study’s authors argue their findings are a strong argument for rethinking current treatment guidelines.
Learn more

FDA approves Ocrevus Zunovo for relapsing and primary progressive MS

September 16, 2024

Treatment has the potential to expand options to centers without IV infrastructure or with IV constraints.
Learn more

Study provides insights into how brain regenerates lost myelin

September 12, 2024

The findings could have important implications for the ongoing effort to develop new and improved therapies for the treatment of demyelinating diseases.
Learn more

Combination therapy holds promise as MS treatment

October 04, 2024

Results could lead to a new, more potent option for patients.
Learn more

Applying for disaster relief

October 01, 2024

Instructions for individuals with MS who need disaster relief
Learn more

MS symptoms at onset linked to long-term disability

September 30, 2024

New study reveals blurry vision and sphincter dysfunction as key predictors of functional outcomes in MS patients.
Learn more

Support disaster relief for people with MS

September 30, 2024

Give or get support for disaster relief for people with MS.
Learn more

New study uncovers therapeutic inertia in the treatment of women with MS

September 27, 2024

The findings highlight gender disparities that could affect long-term health outcomes for women of childbearing age.
Learn more

Study finds ancestry-specific genetic variants linked to MS risk

September 24, 2024

Uncovered novel ancestry-specific genetic variants found to be linked to disease.
Learn more

Early high-efficacy treatment reduces long-term disability in children with MS

September 23, 2024

The study’s authors argue their findings are a strong argument for rethinking current treatment guidelines.
Learn more

FDA approves Ocrevus Zunovo for relapsing and primary progressive MS

September 16, 2024

Treatment has the potential to expand options to centers without IV infrastructure or with IV constraints.
Learn more

Study provides insights into how brain regenerates lost myelin

September 12, 2024

The findings could have important implications for the ongoing effort to develop new and improved therapies for the treatment of demyelinating diseases.
Learn more

Study reveals molecular mechanism behind MS

August 30, 2024

The findings suggest a new target for a universal treatment for human autoimmune disease.
Learn more

Human stem cell models point to glia as key players in MS

August 29, 2024

Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments.
Learn more

Study suggests MS may protect against Alzheimer’s disease

August 27, 2024

The findings support observations that Alzheimer’s appeared to be less likely to develop among those with MS.
Learn more

COVID-19 vaccine not tied to MS relapse

August 16, 2024

The absence of such a risk is encouraging for people with MS so they may receive booster shots when needed.
Learn more

Study reveals unique histone tag in adult oligodendrocyte progenitor cells

August 13, 2024

The findings may help advance development of new therapies for neurodegenerative diseases such as multiple sclerosis.
Learn more

Current challenges evaluated for measuring and treating fatigue in MS

August 09, 2024

New study sheds light on defining, assessing, and addressing MS-related fatigue
Learn more

Researchers seek participants for MS study

August 07, 2024

Program to test effects of exercise on physical and brain function.
Learn more

Researchers: Machine learning models may enhance planning for people with MS

August 02, 2024

The study found the history of disability progression was more predictive for future disability progression than treatment or relapse history.
Learn more

New therapeutic target offers a promising pathway for MS treatment

July 29, 2024

Researchers find that blocking an overproduced channel protein may improve symptoms in an animal model of MS.
Learn more


Show More News